Deep Brain Stimulation of Nucleus Accumbens for Methamphetamine Addiction
Not Applicable
- Conditions
- Treatment Methamphetamine Addiction
- Interventions
- Procedure: Bilateral surgical implantation of DBS system to NAc
- Registration Number
- NCT03347474
- Lead Sponsor
- Ruijin Hospital
- Brief Summary
The main objective of this study is to assess the efficacy of bilateral deep brain stimulation (DBS) of the Nucleus Accumbens(NAc) as a novel treatment in severe methamphetamine addiction. Our hypothesis is that bilateral DBS of the NAc will significantly reduce the craving for methamphetamine.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
- DSM-IV-TR diagnosis of Drug addiction disorder;
- Age 18-65 years old;
- Proficiency in Mandarin language;
- Failure to detox more than three times;
- Capacity to provide informed consent (understanding of the study purpose and methods);
Exclusion Criteria
- Multidrug abuse and formation of addiction;
- Serious and unstable organic diseases (e.g. unstable coronal heart disease);
- Any history of seizure disorder or hemorrhagic stroke;
- Past stereotactic neurosurgical intervention;
- Neurological disease (Abnormal PET-CT, MRI, EEG)
- Contraindications of MRI-examination, e.g. implanted cardiac pacemaker/ heart defibrillator;
- Contraindications of stereotactic intervention, e.g. increased bleeding disposition, cerebrovascular diseases (e.g. arteriovenous malfunction, aneurysms, systemic vascular diseases);
- HIV positive;
- Pregnancy and/or lactation;
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Bilateral surgical implantation of DBS system to NAc Bilateral surgical implantation of DBS system to NAc -
- Primary Outcome Measures
Name Time Method change in 10-point visual analog scale of carving Baseline (preoperative),3 months,6 months, 12 months The score of scale is from 0 to 10. 0 represents no carving for drug, 10 means the greatest degree of carving for drug.
change in Obsessive Compulsive Drug Use Scale Baseline (preoperative),3 months,6 months, 12 months
- Secondary Outcome Measures
Name Time Method Change in the Hamilton Anxiety Scale Baseline(preoperative),3 months, 6 months, 12months Change in the Hamilton Depression Scale Baseline(preoperative),3 months, 6 months, 12 months Change in the Quality of Life Assessment (SF-36) Baseline(preoperative),3 months, 6 months, 12 months Chang in Pittsburgh Sleep Quality Index Baseline(preoperative),3 months,6 months, 12 months Neuropsychological measures(Scores of cognitive battery) Baseline(preoperative),6 months,12 months Side Effect Baseline(preoperative),3 months, 6 months, 12months Change in World Health Organization Quality of Life-BREF(WHO-BREF) Baseline(preoperative),3 months,6 months, 12 months Change in Fagerstrom Test of Nicotine Dependence(FTND) Baseline(preoperative),3 months,6 months, 12 months
Trial Locations
- Locations (1)
Shanghai Ruijin Hospital Functional Neurosurgery
🇨🇳Shanghai, Shanghai, China